Development and pharmacological evaluation of an intranasal liposomal norbinaltorphimine formulation for the prevention of pain-induced negative affect

Jesús D. Lorente, Yolanda Campos-Jurado, Miquel Martínez-Navarrete, Javier Cuitavi, Marta Cervera-Sospedra, Jessica A. Higginbotham, Ana Melero, Ana Polache, Antonio J. Guillot, Jose A. Morón, Lucía Hipólito

Open source

DOI
10.64898/2026.08.26.747378
Published
2026-09-01
Container
Not recorded
Publisher
openRxiv
Open access
unknown

Credibility signals

uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.64898/2026.08.26.747378,
  title = {Development and pharmacological evaluation of an intranasal liposomal norbinaltorphimine formulation for the prevention of pain-induced negative affect},
  author = {Jesús D. Lorente and Yolanda Campos-Jurado and Miquel Martínez-Navarrete and Javier Cuitavi and Marta Cervera-Sospedra and Jessica A. Higginbotham and Ana Melero and Ana Polache and Antonio J. Guillot and Jose A. Morón and Lucía Hipólito},
  year = {2026},
  doi = {10.64898/2026.08.26.747378},
  url = {https://doi.org/10.64898/2026.08.26.747378}
}

RIS

TY  - JOUR
TI  - Development and pharmacological evaluation of an intranasal liposomal norbinaltorphimine formulation for the prevention of pain-induced negative affect
AU  - Jesús D. Lorente
AU  - Yolanda Campos-Jurado
AU  - Miquel Martínez-Navarrete
AU  - Javier Cuitavi
AU  - Marta Cervera-Sospedra
AU  - Jessica A. Higginbotham
AU  - Ana Melero
AU  - Ana Polache
AU  - Antonio J. Guillot
AU  - Jose A. Morón
AU  - Lucía Hipólito
PY  - 2026
DO  - 10.64898/2026.08.26.747378
UR  - https://doi.org/10.64898/2026.08.26.747378
ER  - 

APA

Lorente, J. D., Campos-Jurado, Y., Martínez-Navarrete, M., Cuitavi, J., Cervera-Sospedra, M., Higginbotham, J. A., Melero, A., Polache, A., Guillot, A. J., Morón, J. A., & Hipólito, L. (2026). Development and pharmacological evaluation of an intranasal liposomal norbinaltorphimine formulation for the prevention of pain-induced negative affect. https://doi.org/10.64898/2026.08.26.747378

Source records